Maryland Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Hold |
65
| – | – | 0.01% | 154 |
|
|
2025
Q1 | $41.2K | Hold |
65
| – | – | 0.02% | 132 |
|
|
2024
Q4 | $46.3K | Sell |
65
-65
| -50% | -$46.3K | 0.02% | 133 |
|
|
2024
Q3 | $137K | Hold |
130
| – | – | 0.07% | 82 |
|
|
2024
Q2 | $137K | Hold |
130
| – | – | 0.07% | 82 |
|
|
2024
Q1 | $125K | Hold |
130
| – | – | 0.08% | 83 |
|
|
2023
Q4 | $114K | Hold |
130
| – | – | 0.08% | 82 |
|
|
2023
Q3 | $107K | Hold |
130
| – | – | 0.08% | 78 |
|
|
2023
Q2 | $93.4K | Hold |
130
| – | – | 0.08% | 88 |
|
|
2023
Q1 | $107K | Hold |
130
| – | – | 0.09% | 83 |
|
|
2022
Q4 | $93.8K | Hold |
130
| – | – | 0.09% | 86 |
|
|
2022
Q3 | $90K | Hold |
130
| – | – | 0.09% | 74 |
|
|
2022
Q2 | $77K | Buy |
+130
| New | +$77K | 0.08% | 79 |
|